Arcadia Biosciences, Inc.

Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) and Anheuser-Busch InBev SA/NV (NYSE: BUD - Get Free Report) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, valuation and risk. Valuation and Earnings This table compares

Arcadia Biosciences, Inc. (NASDAQ: RKDA - Get Free Report) saw a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 9,605 shares, a drop of 48.8% from the August 31st total of 18,768 shares. Based on an average daily trading volume, of 54,883 shares, the short-interest

Molson Coors Beverage (NYSE: TAP.A - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends. Valuation and Earnings This table compares

Kirin (OTCMKTS:KNBWY - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Analyst Recommendations This is a summary of current